GLA
ANIP icon

Great Lakes Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

Great Lakes Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.09M Sell
61,481
-5,649
-8% -$453K 0.04% 231
2026
Q1 		$5.16M Buy
67,130
+7,495
+13% +$585K 0.04% 219
2025
Q4 		$4.71M Hold
59,635
– – 0.04% 247
2025
Q3 		$5.46M Sell
59,635
-5,168
-8% -$421K 0.05% 234
2025
Q2 		$4.23M Sell
64,803
-2,033
-3% -$132K 0.04% 319
2025
Q1 		$4.47M Sell
66,836
-7,391
-10% -$441K 0.04% 295
2024
Q4 		$4.1M Buy
74,227
+3,591
+5% +$206K 0.04% 367
2024
Q3 		$4.21M Buy
70,636
+14,555
+26% +$888K 0.04% 377
2024
Q2 		$3.57M Buy
56,081
+5,359
+11% +$348K 0.03% 385
2024
Q1 		$3.51M Buy
50,722
+2,470
+5% +$149K 0.03% 399
2023
Q4 		$2.66M Buy
48,252
+19,378
+67% +$1.07M 0.03% 426
2023
Q3 		$1.68M Buy
28,874
+6,909
+31% +$399K 0.02% 469
2023
Q2 		$1.18M Sell
21,965
-30,130
-58% -$1.34M 0.01% 505
2023
Q1 		$2.07M Buy
+52,095
New +$2.2M 0.02% 495

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Great Lakes Advisors's ANIP Position: Q2 2026 in Review

Great Lakes Advisors reduced its ANI Pharmaceuticals (ANIP) stake by 8.4% in Q2 2026, selling an estimated $453K and leaving 61,481 shares worth $5.09M. The position accounts for 0.04% of the portfolio, ranked #231.

Great Lakes Advisors first reported a position in ANIP in Q1 2023 and has held it in 14 quarters since. The position peaked at $5.46M in Q3 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Great Lakes Advisors held 61,481 shares of ANI Pharmaceuticals worth $5.09M as of Q2 2026.
  • Great Lakes Advisors sold 5,649 ANI Pharmaceuticals shares in Q2 2026, an estimated $453K.
  • ANI Pharmaceuticals made up 0.04% of Great Lakes Advisors's portfolio in Q2 2026, its #231 holding.
  • Great Lakes Advisors first reported a position in ANI Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
  • Great Lakes Advisors's ANI Pharmaceuticals position peaked at $5.46M in Q3 2025.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Great Lakes Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.